JP2012501680A - クリーンゲノムバクトフェクション - Google Patents
クリーンゲノムバクトフェクション Download PDFInfo
- Publication number
- JP2012501680A JP2012501680A JP2011527024A JP2011527024A JP2012501680A JP 2012501680 A JP2012501680 A JP 2012501680A JP 2011527024 A JP2011527024 A JP 2011527024A JP 2011527024 A JP2011527024 A JP 2011527024A JP 2012501680 A JP2012501680 A JP 2012501680A
- Authority
- JP
- Japan
- Prior art keywords
- gene
- cells
- replication
- bacterium
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 273
- 210000004027 cell Anatomy 0.000 claims abstract description 178
- 241000894006 Bacteria Species 0.000 claims abstract description 167
- 230000014509 gene expression Effects 0.000 claims abstract description 131
- 238000000034 method Methods 0.000 claims abstract description 125
- 230000002829 reductive effect Effects 0.000 claims abstract description 51
- 210000004102 animal cell Anatomy 0.000 claims abstract description 36
- 208000015181 infectious disease Diseases 0.000 claims abstract description 24
- 108091023040 Transcription factor Proteins 0.000 claims abstract description 23
- 102000040945 Transcription factor Human genes 0.000 claims abstract description 23
- 210000001082 somatic cell Anatomy 0.000 claims abstract description 23
- 102000002584 Octamer Transcription Factor-3 Human genes 0.000 claims abstract 3
- 108010068425 Octamer Transcription Factor-3 Proteins 0.000 claims abstract 3
- 108010048992 Transcription Factor 4 Proteins 0.000 claims abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 84
- 239000013598 vector Substances 0.000 claims description 65
- 241000588724 Escherichia coli Species 0.000 claims description 64
- 230000010076 replication Effects 0.000 claims description 51
- 241000607768 Shigella Species 0.000 claims description 49
- 150000007523 nucleic acids Chemical class 0.000 claims description 38
- 102000039446 nucleic acids Human genes 0.000 claims description 36
- 108020004707 nucleic acids Proteins 0.000 claims description 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 32
- 230000000694 effects Effects 0.000 claims description 26
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 19
- 210000001519 tissue Anatomy 0.000 claims description 16
- 210000005260 human cell Anatomy 0.000 claims description 15
- 230000001939 inductive effect Effects 0.000 claims description 15
- 229920001184 polypeptide Polymers 0.000 claims description 15
- 210000002950 fibroblast Anatomy 0.000 claims description 14
- 210000004413 cardiac myocyte Anatomy 0.000 claims description 13
- 241000894007 species Species 0.000 claims description 13
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 12
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 12
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 238000007710 freezing Methods 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 11
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 claims description 10
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 10
- 230000000747 cardiac effect Effects 0.000 claims description 10
- 239000003550 marker Substances 0.000 claims description 10
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 9
- 108020005091 Replication Origin Proteins 0.000 claims description 9
- 210000002216 heart Anatomy 0.000 claims description 9
- 210000000130 stem cell Anatomy 0.000 claims description 9
- 230000001131 transforming effect Effects 0.000 claims description 9
- 102100024642 ATP-binding cassette sub-family C member 9 Human genes 0.000 claims description 8
- 108050008988 ATP-binding cassette subfamily C member 9 Proteins 0.000 claims description 8
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 8
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 8
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 claims description 8
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 claims description 8
- 102000016878 Hypoxia-Inducible Factor 1 Human genes 0.000 claims description 8
- 108010028501 Hypoxia-Inducible Factor 1 Proteins 0.000 claims description 8
- 102000008052 Nitric Oxide Synthase Type III Human genes 0.000 claims description 8
- 108010075520 Nitric Oxide Synthase Type III Proteins 0.000 claims description 8
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 8
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 claims description 8
- 101150072501 Klf2 gene Proteins 0.000 claims description 6
- 102000007469 Actins Human genes 0.000 claims description 5
- 108010085238 Actins Proteins 0.000 claims description 5
- 101100342337 Caenorhabditis elegans klf-1 gene Proteins 0.000 claims description 5
- 102000002737 Heme Oxygenase-1 Human genes 0.000 claims description 5
- 108010018924 Heme Oxygenase-1 Proteins 0.000 claims description 5
- 241000186781 Listeria Species 0.000 claims description 5
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 230000008952 bacterial invasion Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 229940037201 oris Drugs 0.000 claims description 5
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 claims description 4
- 101000936911 Chionoecetes opilio Sarcoplasmic/endoplasmic reticulum calcium ATPase Proteins 0.000 claims description 4
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims description 4
- 102100027732 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Human genes 0.000 claims description 4
- 101710109123 Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Proteins 0.000 claims description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 4
- 108010017842 Telomerase Proteins 0.000 claims description 4
- 108010051583 Ventricular Myosins Proteins 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
- 108091006112 ATPases Proteins 0.000 claims description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 3
- 241000606701 Rickettsia Species 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 3
- 230000001605 fetal effect Effects 0.000 claims description 3
- 210000003953 foreskin Anatomy 0.000 claims description 3
- 101150111214 lin-28 gene Proteins 0.000 claims description 3
- 102000008102 Ankyrins Human genes 0.000 claims description 2
- 108010049777 Ankyrins Proteins 0.000 claims description 2
- 108090000362 Lymphotoxin-beta Proteins 0.000 claims description 2
- 108060008487 Myosin Proteins 0.000 claims description 2
- 102000003505 Myosin Human genes 0.000 claims description 2
- 102100026057 Myosin regulatory light chain 2, atrial isoform Human genes 0.000 claims description 2
- 101710098224 Myosin regulatory light chain 2, atrial isoform Proteins 0.000 claims description 2
- 102000013534 Troponin C Human genes 0.000 claims description 2
- 102000004987 Troponin T Human genes 0.000 claims description 2
- 108090001108 Troponin T Proteins 0.000 claims description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 2
- 102100023489 Transcription factor 4 Human genes 0.000 claims 2
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 claims 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 claims 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims 1
- 102000017100 SOX Transcription Factors Human genes 0.000 claims 1
- 108010013721 SOX Transcription Factors Proteins 0.000 claims 1
- 210000001626 skin fibroblast Anatomy 0.000 claims 1
- 210000001988 somatic stem cell Anatomy 0.000 claims 1
- 229940032362 superoxide dismutase Drugs 0.000 claims 1
- 230000000392 somatic effect Effects 0.000 abstract description 2
- 102000009523 Transcription Factor 4 Human genes 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 105
- 229960005486 vaccine Drugs 0.000 description 77
- 108020004414 DNA Proteins 0.000 description 76
- 230000001580 bacterial effect Effects 0.000 description 71
- 239000000427 antigen Substances 0.000 description 57
- 108091007433 antigens Proteins 0.000 description 55
- 102000036639 antigens Human genes 0.000 description 54
- 230000032258 transport Effects 0.000 description 49
- 102000004169 proteins and genes Human genes 0.000 description 48
- 235000018102 proteins Nutrition 0.000 description 46
- 230000009545 invasion Effects 0.000 description 43
- 238000012217 deletion Methods 0.000 description 33
- 230000037430 deletion Effects 0.000 description 33
- 239000012634 fragment Substances 0.000 description 32
- 108010079723 Shiga Toxin Proteins 0.000 description 31
- 108010090763 Shiga Toxin 2 Proteins 0.000 description 30
- 244000052769 pathogen Species 0.000 description 28
- 241000699670 Mus sp. Species 0.000 description 26
- 230000001018 virulence Effects 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 22
- 230000002163 immunogen Effects 0.000 description 22
- 108700012359 toxins Proteins 0.000 description 22
- 108010041986 DNA Vaccines Proteins 0.000 description 21
- 229940021995 DNA vaccine Drugs 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 21
- 230000002068 genetic effect Effects 0.000 description 21
- 230000012010 growth Effects 0.000 description 20
- 210000004962 mammalian cell Anatomy 0.000 description 20
- 230000001717 pathogenic effect Effects 0.000 description 20
- 231100000765 toxin Toxicity 0.000 description 20
- 239000003053 toxin Substances 0.000 description 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 18
- 230000001681 protective effect Effects 0.000 description 17
- 101150003560 trfA gene Proteins 0.000 description 17
- 241000607142 Salmonella Species 0.000 description 16
- 230000009089 cytolysis Effects 0.000 description 16
- 230000028993 immune response Effects 0.000 description 16
- 230000006798 recombination Effects 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 230000006698 induction Effects 0.000 description 15
- 238000005215 recombination Methods 0.000 description 15
- 241000725303 Human immunodeficiency virus Species 0.000 description 14
- 230000036039 immunity Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 description 13
- 230000002238 attenuated effect Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 238000012986 modification Methods 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 238000012546 transfer Methods 0.000 description 13
- 230000009466 transformation Effects 0.000 description 13
- 108700039887 Essential Genes Proteins 0.000 description 12
- 238000000338 in vitro Methods 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 12
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000013518 transcription Methods 0.000 description 12
- 102100026189 Beta-galactosidase Human genes 0.000 description 11
- 238000013459 approach Methods 0.000 description 11
- 108010005774 beta-Galactosidase Proteins 0.000 description 11
- 230000035772 mutation Effects 0.000 description 11
- 101150079601 recA gene Proteins 0.000 description 11
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 230000035897 transcription Effects 0.000 description 11
- 241000700605 Viruses Species 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000001976 improved effect Effects 0.000 description 10
- 230000037431 insertion Effects 0.000 description 10
- 238000003780 insertion Methods 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 241001646716 Escherichia coli K-12 Species 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 9
- 210000001744 T-lymphocyte Anatomy 0.000 description 9
- 208000037386 Typhoid Diseases 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 101150114988 invA gene Proteins 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 201000008297 typhoid fever Diseases 0.000 description 9
- 101710198693 Invasin Proteins 0.000 description 8
- 108091005804 Peptidases Proteins 0.000 description 8
- 210000000349 chromosome Anatomy 0.000 description 8
- 210000001072 colon Anatomy 0.000 description 8
- 238000004520 electroporation Methods 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 230000005847 immunogenicity Effects 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 230000007918 pathogenicity Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 238000001890 transfection Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 206010059866 Drug resistance Diseases 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 229930182566 Gentamicin Natural products 0.000 description 6
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 6
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 6
- 230000000890 antigenic effect Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000013613 expression plasmid Substances 0.000 description 6
- 238000001415 gene therapy Methods 0.000 description 6
- 229960002518 gentamicin Drugs 0.000 description 6
- 230000005571 horizontal transmission Effects 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 101150066555 lacZ gene Proteins 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 230000003071 parasitic effect Effects 0.000 description 6
- 229960005322 streptomycin Drugs 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 101150116095 uhpT gene Proteins 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 5
- 108091029865 Exogenous DNA Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 108010091769 Shiga Toxin 1 Proteins 0.000 description 5
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- -1 antibodies Proteins 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000002759 chromosomal effect Effects 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 210000000172 cytosol Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000012636 effector Substances 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 231100000518 lethal Toxicity 0.000 description 5
- 230000001665 lethal effect Effects 0.000 description 5
- 238000006386 neutralization reaction Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 230000000069 prophylactic effect Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000010361 transduction Methods 0.000 description 5
- 230000026683 transduction Effects 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 4
- 108020005544 Antisense RNA Proteins 0.000 description 4
- 108700023313 Bacteriophage Receptors Proteins 0.000 description 4
- 108090000994 Catalytic RNA Proteins 0.000 description 4
- 102000053642 Catalytic RNA Human genes 0.000 description 4
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 4
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
- 102100037850 Interferon gamma Human genes 0.000 description 4
- 108010074328 Interferon-gamma Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 101710150114 Protein rep Proteins 0.000 description 4
- 101710152114 Replication protein Proteins 0.000 description 4
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- 241000607626 Vibrio cholerae Species 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 229960001212 bacterial vaccine Drugs 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000003119 immunoblot Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000009465 prokaryotic expression Effects 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 108091092562 ribozyme Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241001430294 unidentified retrovirus Species 0.000 description 4
- 210000003934 vacuole Anatomy 0.000 description 4
- 229940118696 vibrio cholerae Drugs 0.000 description 4
- 244000052613 viral pathogen Species 0.000 description 4
- 241000193738 Bacillus anthracis Species 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 102100025137 Early activation antigen CD69 Human genes 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 101710121417 Envelope glycoprotein Proteins 0.000 description 3
- 101100390711 Escherichia coli (strain K12) fhuA gene Proteins 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 241000713800 Feline immunodeficiency virus Species 0.000 description 3
- 208000031448 Genomic Instability Diseases 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 229940033330 HIV vaccine Drugs 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 3
- 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 3
- 241000701806 Human papillomavirus Species 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- 241000186779 Listeria monocytogenes Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 108091008109 Pseudogenes Proteins 0.000 description 3
- 102000057361 Pseudogenes Human genes 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 101150086694 SLC22A3 gene Proteins 0.000 description 3
- 101150001411 STX2 gene Proteins 0.000 description 3
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
- 241000242678 Schistosoma Species 0.000 description 3
- 241000607762 Shigella flexneri Species 0.000 description 3
- 230000005875 antibody response Effects 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 230000008348 humoral response Effects 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 239000002955 immunomodulating agent Substances 0.000 description 3
- 229940121354 immunomodulator Drugs 0.000 description 3
- 238000007912 intraperitoneal administration Methods 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 231100000636 lethal dose Toxicity 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002101 lytic effect Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 101150021607 rppH gene Proteins 0.000 description 3
- 101150082821 sacA gene Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 229940125575 vaccine candidate Drugs 0.000 description 3
- 101150070603 yadA gene Proteins 0.000 description 3
- MIAKOEWBCMPCQR-YBXAARCKSA-N (2s,3r,4s,5r,6r)-2-(4-aminophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=CC(N)=CC=C1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MIAKOEWBCMPCQR-YBXAARCKSA-N 0.000 description 2
- VDABVNMGKGUPEY-UHFFFAOYSA-N 6-carboxyfluorescein succinimidyl ester Chemical compound C=1C(O)=CC=C2C=1OC1=CC(O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O VDABVNMGKGUPEY-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- NGNQZCDZXSOVQU-UHFFFAOYSA-N 8,16,18,26,34,36-hexahydroxyhentetracontane-2,6,10,14,24,28,32-heptone Chemical compound CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCC(C)=O NGNQZCDZXSOVQU-UHFFFAOYSA-N 0.000 description 2
- 101100002068 Bacillus subtilis (strain 168) araR gene Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108010041397 CD4 Antigens Proteins 0.000 description 2
- 101100257372 Caenorhabditis elegans sox-3 gene Proteins 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
- 241001115402 Ebolavirus Species 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 241000711549 Hepacivirus C Species 0.000 description 2
- 101000899111 Homo sapiens Hemoglobin subunit beta Proteins 0.000 description 2
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
- 206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 2
- 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- 101100310657 Mus musculus Sox1 gene Proteins 0.000 description 2
- 101100257376 Mus musculus Sox3 gene Proteins 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 108091061960 Naked DNA Proteins 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- 108010013639 Peptidoglycan Proteins 0.000 description 2
- 108010090127 Periplasmic Proteins Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000242677 Schistosoma japonicum Species 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 101150001847 Sox15 gene Proteins 0.000 description 2
- 230000005867 T cell response Effects 0.000 description 2
- 108010069584 Type III Secretion Systems Proteins 0.000 description 2
- 101100398736 Yersinia pestis lcrF gene Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 101150044616 araC gene Proteins 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 210000003578 bacterial chromosome Anatomy 0.000 description 2
- 230000008956 bacterial persistence Effects 0.000 description 2
- 230000008955 bacterial trafficking Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 101150008507 dnaE gene Proteins 0.000 description 2
- 230000003828 downregulation Effects 0.000 description 2
- 238000004836 empirical method Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000009650 gentamicin protection assay Methods 0.000 description 2
- 229930186900 holotoxin Natural products 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 210000003071 memory t lymphocyte Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000016379 mucosal immune response Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 210000001322 periplasm Anatomy 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 210000001778 pluripotent stem cell Anatomy 0.000 description 2
- 101150060505 polC gene Proteins 0.000 description 2
- 230000001124 posttranscriptional effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000012846 protein folding Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 231100000654 protein toxin Toxicity 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 108010054624 red fluorescent protein Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229940031626 subunit vaccine Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000003501 vero cell Anatomy 0.000 description 2
- 101150076562 virB gene Proteins 0.000 description 2
- 101150103224 virF gene Proteins 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- 230000007923 virulence factor Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 2
- 108020005096 28S Ribosomal RNA Proteins 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 108010083528 Adenylate Cyclase Toxin Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 101710203310 Apical membrane antigen 1 Proteins 0.000 description 1
- 241000223836 Babesia Species 0.000 description 1
- 108010037833 Bacterial Adhesins Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000908522 Borreliella Species 0.000 description 1
- 241000244036 Brugia Species 0.000 description 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 206010061764 Chromosomal deletion Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108010071146 DNA Polymerase III Proteins 0.000 description 1
- 102000007528 DNA Polymerase III Human genes 0.000 description 1
- 102000006465 DNA Restriction-Modification Enzymes Human genes 0.000 description 1
- 108010044289 DNA Restriction-Modification Enzymes Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000714165 Feline leukemia virus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 108090001126 Furin Proteins 0.000 description 1
- 101710093554 Galactose-specific lectin Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 241000224466 Giardia Species 0.000 description 1
- 101710178393 Globin-like protein Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 229940033332 HIV-1 vaccine Drugs 0.000 description 1
- 241001446459 Heia Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101700012268 Holin Proteins 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 101900228213 Human herpesvirus 2 Envelope glycoprotein D Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108010002231 IgA-specific serine endopeptidase Proteins 0.000 description 1
- 102000012355 Integrin beta1 Human genes 0.000 description 1
- 108010022222 Integrin beta1 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 101710167241 Intimin Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108010017123 Kruppel-Like Transcription Factors Proteins 0.000 description 1
- 102000004434 Kruppel-Like Transcription Factors Human genes 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- 108700041076 Leishmania glycoprotein gp63 Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 108700027766 Listeria monocytogenes hlyA Proteins 0.000 description 1
- 108010066345 MHC binding peptide Proteins 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 101710164702 Major outer membrane protein Proteins 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 101100043729 Mus musculus Stx2 gene Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000243981 Onchocerca Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 108010092528 Phosphate Transport Proteins Proteins 0.000 description 1
- 102000016462 Phosphate Transport Proteins Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 102000018819 Protein Translocation Systems Human genes 0.000 description 1
- 102100025460 Protein lin-28 homolog A Human genes 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 101150090155 R gene Proteins 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 102000002278 Ribosomal Proteins Human genes 0.000 description 1
- 108010000605 Ribosomal Proteins Proteins 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101150010882 S gene Proteins 0.000 description 1
- 101000801721 Schistosoma mansoni Triosephosphate isomerase Proteins 0.000 description 1
- 241000147000 Shigella flexneri 2a Species 0.000 description 1
- 101100219435 Shigella flexneri can gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101800001707 Spacer peptide Proteins 0.000 description 1
- 208000029033 Spinal Cord disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 101710182223 Toxin B Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000005937 Tropomyosin Human genes 0.000 description 1
- 108010030743 Tropomyosin Proteins 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108010003026 UDP-3-O-acyl-N-acetylglucosamine deacetylase Proteins 0.000 description 1
- 102000003848 Uteroglobin Human genes 0.000 description 1
- 108090000203 Uteroglobin Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 101710201961 Virion infectivity factor Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000000961 alloantigen Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940125644 antibody drug Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 229940031567 attenuated vaccine Drugs 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
- JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000006395 clathrin-mediated endocytosis Effects 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000003740 cowpox Diseases 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 101150012763 endA gene Proteins 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000026502 entry into host cell Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108010008385 glycolipid receptor Proteins 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 108060003552 hemocyanin Proteins 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 101150006815 icsA gene Proteins 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 210000004201 immune sera Anatomy 0.000 description 1
- 229940042743 immune sera Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 108091006086 inhibitor proteins Proteins 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000013101 initial test Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 102000007236 involucrin Human genes 0.000 description 1
- 108010033564 involucrin Proteins 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 101150033242 lpxC gene Proteins 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000013227 macrophage apoptotic process Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000009126 molecular therapy Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940051921 muramidase Drugs 0.000 description 1
- 229940114179 mycobacterium bovis Drugs 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 230000001937 non-anti-biotic effect Effects 0.000 description 1
- 230000030648 nucleus localization Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940023041 peptide vaccine Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 108010021711 pertactin Proteins 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000009163 protein therapy Methods 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 229940045847 receptor mimetic Drugs 0.000 description 1
- 108010043277 recombinant soluble CD4 Proteins 0.000 description 1
- 230000001373 regressive effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000007441 retrograde transport Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 231100000617 superantigen Toxicity 0.000 description 1
- 229940126577 synthetic vaccine Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 108010044241 tetanus toxin fragment C Proteins 0.000 description 1
- 101150046628 thrS gene Proteins 0.000 description 1
- 101150031421 thrS-cat gene Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000723 toxicological property Toxicity 0.000 description 1
- 230000007888 toxin activity Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000003146 transient transfection Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229940124856 vaccine component Drugs 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 108700026215 vpr Genes Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9664908P | 2008-09-12 | 2008-09-12 | |
| US61/096,649 | 2008-09-12 | ||
| PCT/US2009/056829 WO2010030986A2 (en) | 2008-09-12 | 2009-09-14 | Clean genome bactofection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012501680A true JP2012501680A (ja) | 2012-01-26 |
| JP2012501680A5 JP2012501680A5 (enExample) | 2012-11-01 |
Family
ID=41328762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527024A Pending JP2012501680A (ja) | 2008-09-12 | 2009-09-14 | クリーンゲノムバクトフェクション |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110165680A1 (enExample) |
| EP (1) | EP2344646A2 (enExample) |
| JP (1) | JP2012501680A (enExample) |
| CA (1) | CA2736877A1 (enExample) |
| WO (1) | WO2010030986A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022554070A (ja) * | 2019-09-25 | 2022-12-28 | カトリーケ、ユニベルシテート、ルーベン | 高収量生産のための巨大ベクターおよび方法 |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ593926A (en) * | 2009-01-23 | 2013-03-28 | Jackson H M Found Military Med | Methods and compositions based on shiga toxin type 2 protein |
| WO2013025248A1 (en) * | 2011-08-12 | 2013-02-21 | Mello Biotechnology, Inc. | Inducable expression from the eukaryotic pol -2 promoter in prokaryotes |
| EP2758530A4 (en) * | 2011-09-22 | 2015-04-29 | Jackson H M Found Military Med | SHIGELLA-DERIVED VECTOR AND USE METHOD THEREFOR |
| US11680273B2 (en) | 2011-09-23 | 2023-06-20 | Loma Linda University | Treatment of autoimmune diseases |
| DK2758074T3 (da) | 2011-09-23 | 2020-07-27 | Univ Loma Linda | Bakteriestammer der udtrykker methylasegener og anvendelser deraf |
| US10196662B2 (en) * | 2012-08-10 | 2019-02-05 | Mello Biotechnology, Inc. | Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| WO2019205057A1 (zh) * | 2018-04-26 | 2019-10-31 | 广州中科蓝华生物科技有限公司 | 一种启动子及其应用 |
| CN109402155A (zh) * | 2018-11-12 | 2019-03-01 | 川北医学院 | 一种双控延迟裂解性质粒及其构建方法与应用 |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| MY209860A (en) | 2020-02-13 | 2025-08-07 | Tenaya Therapeutics Inc | Gene therapy vectors for treating heart disease |
| US20240261394A1 (en) * | 2020-05-11 | 2024-08-08 | University Of Virginia Patent Foundation | Compositions and methods for inducing immune responses against class i fusion protein viruses |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| EP4346897A4 (en) * | 2021-06-02 | 2025-07-23 | Sivec Biotechnologies Llc | BACTERIAL DELIVERY OF ANTIBODIES, ANTIBODY DERIVATIVES AND POLYPEPTIDES TO EUKARYOTIC CELLS |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070880A2 (en) * | 2002-01-23 | 2003-08-28 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
| WO2007024756A2 (en) * | 2005-08-20 | 2007-03-01 | Scarab Genomics, Llc | Reduced genome e. coli |
| WO2007069666A1 (ja) * | 2005-12-13 | 2007-06-21 | Kyoto University | 核初期化因子 |
| WO2007118162A1 (en) * | 2006-04-07 | 2007-10-18 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| WO2008017073A2 (en) * | 2006-08-03 | 2008-02-07 | Wisconsin Alumni Research Foundation | Vector systems |
-
2009
- 2009-09-14 US US13/063,450 patent/US20110165680A1/en not_active Abandoned
- 2009-09-14 CA CA2736877A patent/CA2736877A1/en not_active Abandoned
- 2009-09-14 EP EP09792511A patent/EP2344646A2/en not_active Withdrawn
- 2009-09-14 JP JP2011527024A patent/JP2012501680A/ja active Pending
- 2009-09-14 WO PCT/US2009/056829 patent/WO2010030986A2/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003070880A2 (en) * | 2002-01-23 | 2003-08-28 | Wisconsin Alumni Research Foundation | Bacteria with reduced genome |
| WO2007024756A2 (en) * | 2005-08-20 | 2007-03-01 | Scarab Genomics, Llc | Reduced genome e. coli |
| WO2007069666A1 (ja) * | 2005-12-13 | 2007-06-21 | Kyoto University | 核初期化因子 |
| WO2007118162A1 (en) * | 2006-04-07 | 2007-10-18 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| WO2008017073A2 (en) * | 2006-08-03 | 2008-02-07 | Wisconsin Alumni Research Foundation | Vector systems |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022554070A (ja) * | 2019-09-25 | 2022-12-28 | カトリーケ、ユニベルシテート、ルーベン | 高収量生産のための巨大ベクターおよび方法 |
| JP7618656B2 (ja) | 2019-09-25 | 2025-01-21 | カトリーケ、ユニベルシテート、ルーベン | 高収量生産のための巨大ベクターおよび方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010030986A3 (en) | 2010-06-24 |
| CA2736877A1 (en) | 2010-03-18 |
| EP2344646A2 (en) | 2011-07-20 |
| WO2010030986A2 (en) | 2010-03-18 |
| US20110165680A1 (en) | 2011-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501680A (ja) | クリーンゲノムバクトフェクション | |
| ES2280758T3 (es) | Vectores sitio-especificos de integracion en listeria y procedimientos para la utilizacion de los mismos. | |
| JP2001519162A (ja) | 動物細胞にｒｎａを導入して発現させる方法 | |
| JP3976685B2 (ja) | タンパク質分泌のためのＣｌｙＡ溶血素の使用 | |
| JP2003512077A (ja) | アルファウイルスレプリコンを発現する侵襲性細菌 | |
| JP5665541B2 (ja) | 真核生物ｉ型インタフェロン応答サプレッサー類の共発現による細菌ベースデリバリシステムからのトランスジーン発現の増強方法 | |
| KR20100065243A (ko) | 마이코박테리움의 일렉트로포레이션 및 마이코박테리아에서의 항원의 과발현 | |
| Kramer et al. | Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains | |
| JP5461776B2 (ja) | マイコバクテリウムのエレクトロポレーションおよびマイコバクテリア中における抗原類の過剰発現 | |
| JP2014509513A (ja) | ヘリコバクター・ピロリにおける遺伝子発現および除菌システム | |
| US8053568B2 (en) | Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof | |
| ES2319381T3 (es) | Vacunas virales basadas en bacterias invasivas. | |
| US20080107683A1 (en) | Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof | |
| US20240254167A1 (en) | Genetically modified clostridium strains expressing recombinant antigens and uses thereof | |
| WO2004096288A2 (es) | Método para la obtencion de minicírculos replicativos de adn para transferencia génica o como inmunomoduladores. | |
| Hulbah | Development of an Antibiotic Marker-free Gene Delivery System in Streptococcus Gordonii | |
| Schleef | P/asmids for Therapy and kchation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120913 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120913 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140812 |